Immunoprecipitation - Cecum, liver, and brain tissues were collected in IP lysis buffer (150 mM NaCl, 10 mM Tris-HCl, pH 7.4, 1% NP-40, 1 mM PMSF, and 1 mM protease inhibitor cocktail), homogenized, and incubated on ice for 20 min to ensure complete lysis
Key tips for underwriting applicants with GLP1 use Immediately look for: Evidence of the underlying diagnosis (as seen in medical claims, EHR, APS) Whether the GLP-1 is FDA-approved or off-label for that condition Signs of medication adherence (12 months, regular fills) Get cautious when: A GLP1 appears without any supporting clinical context Fills are intermittent or recently initiated Theres no alignment between the medication and expected companion therapies (e.g., no CPAP with sleep apnea) Be confident when: The diagnosis is clear The drug is first line and clinically appropriate Use has been stable long enough to confer benefit Kyle Schimek, PharmD Kyle Schimek is a board-certified pharmacist and Clinical Services Manager at Milliman IntelliScript
Some products may contain added sugars or artificial flavors, which could counteract the weight loss benefits
Use a circular motion from center outward
